YY2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.681000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.342200E-01
Normal-vs-Stage2
6.047600E-01
Normal-vs-Stage3
4.279400E-01
Normal-vs-Stage4
5.078200E-01
Stage1-vs-Stage2
9.458800E-01
Stage1-vs-Stage3
1.498600E-01
Stage1-vs-Stage4
6.303000E-01
Stage2-vs-Stage3
1.083020E-01
Stage2-vs-Stage4
4.339200E-01
Stage3-vs-Stage4
1.761810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.695000E-01
Normal-vs-AfricanAmerican
4.723600E-01
Normal-vs-Asian
9.283600E-01
Caucasian-vs-AfricanAmerican
4.148200E-01
Caucasian-vs-Asian
5.788400E-01
AfricanAmerican-vs-Asian
4.181000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.384600E-01
Normal-vs-Female
5.785800E-01
Male-vs-Female
3.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.313800E-01
Normal-vs-Age(41-60Yrs)
3.200400E-01
Normal-vs-Age(61-80Yrs)
8.886800E-01
Normal-vs-Age(81-100Yrs)
7.943000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.348000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.600600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.011400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.822100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.236400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.284600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.595800E-01
Normal-vs-Daily Drinker
8.435600E-01
Normal-vs-Weekly Drinker
5.426800E-01
Normal-vs-Occasional Drinker
6.864600E-01
Normal-vs-Social Drinker
4.101400E-01
Non Drinker-vs-Daily Drinker
9.337200E-01
Non Drinker-vs-Weekly Drinker
4.946800E-01
Non Drinker-vs-Occasional Drinker
5.187600E-01
Non Drinker-vs-Social Drinker
1.161150E-01
Daily Drinker-vs-Weekly Drinker
5.851600E-01
Daily Drinker-vs-Occasional Drinker
6.093600E-01
Daily Drinker-vs-Social Drinker
1.789420E-01
Weekly Drinker-vs-Occasional Drinker
9.781800E-01
Weekly Drinker-vs-Social Drinker
3.842200E-01
Occasional Drinker-vs-Social Drinker
4.578400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
1.582980E-01
Grade 1-vs-Grade 3
1.143420E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
5.963000E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.106200E-01
Normal-vs-NonDiabetic
6.790800E-01
Diabetic-vs-NonDiabetic
5.362800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.285000E-01
Normal-vs-NoPancreatitis
7.057800E-01
Pancreatitis-vs-NoPancreatitis
3.359600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.703600E-01
Normal-vs-N1
6.022600E-01
N0-vs-N1
5.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.371200E-01
Normal-vs-TP53-NonMutant
7.322400E-01
TP53-Mutant-vs-TP53-NonMutant
9.693700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
